Natco Gets Defensive As Indian Regulator Threatens Criminal Action For Marketing Substandard Product
This article was originally published in PharmAsia News
Executive Summary
MUMBAI - Albumin-bound paclitaxel drug Abraxane - used in the treatment of breast cancer - has been troubling its innovator, Abraxis Bioscience, and its only Indian generic maker, Natco Pharma, alike